Bolna AS focuses on long-term capital appreciation with a moderate risk profile, balancing stability, diversification, and growth. The portfolio remains fully invested when attractive assets are available without relying on market timing. In uncertain conditions, defensive investments or increased selectivity may be used, but cash is not raised. Investments are concentrated in investment companies, healthcare, and technology. Healthcare provides steady growth and resilience, while technology drives innovation. Risk is minimized through sector and geographic diversification, primarily in Europe and North America. Price declines are a natural part of investing, but missing potential returns due to inaction should be avoided. This disciplined strategy ensures total investment to capture growth potential, providing steady returns and sustainable capital appreciation while adapting to market conditions.
Updated 2024-10-18